The field of tissue engineering integrates the principles of engineering, cell biology and medicine towards the regeneration of specific cells and functional tissue. Matrix associated stem cell implants (MASI) aim to regenerate cartilage defects due to arthritic or traumatic joint injuries. Adult mesenchymal stem cells (MSCs) have the ability to differentiate into cells of the chondrogenic lineage and have shown promising results for cell-based articular cartilage repair technologies. Autologous MSCs can be isolated from a variety of tissues, can be expanded in cell cultures without losing their differentiation potential, and have demonstrated chondrogenic differentiation in vitro and in vivo 1, 2 .
. Coronal T2 weighted SE images (TR 4000 ms/ TE 18.27 ms) of a patella specimen with implanted hMSCs in cartilage defects.
Discussion
The described protocol provides a reproducible way to label MSCs with iron oxide nanoparticles and implant these labeled MSCs into cartilage defects. This technique permits non-invasive depiction of stem cell transplants in cartilage defects with MR imaging, which allows an early detection of MASI failure. A dislocation or efflux of the labeled cells can be diagnosed based on a disappearance of the label from the transplantation site on MR images. An early diagnosis of these events is desirable and would prevent the patient from unnecessary alternative invasive diagnostic procedures. The described non-invasive method for diagnosing MASI outcomes could aid in the successful development of cell based therapies for cartilage regeneration in osteoarthritis. Our protocol is currently applied in preclinical in-vivo studies, would be in principle clinically applicable and could serve as non-invasive outcome measure for the assessment of MASI therapies in clinical practice.
